FDA Investigator Dylan R Jock

Dylan R Jock has conducted inspections on 33 sites in 1 countries as of 21 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

21 May 2024

Investigator Role:

FDA Investigator

Redica ID:

100000976

Countries of Inspections:

United States of America

FDA Investigators that have inspected at least one site in common with Dylan R Jock:

Abby Lmozeke Baker, Amy A Johnson, Arsen Karapetyan, Barbara D Wright, Celeta S Coves, Claude L Brunson, Comyar Shoghi, Courtney N Long, Creighton T Tuzon, Daniell Gill, Jr, Diana L Ayala, Doretha M Tonkins, Doretha M Wilson, Eddie J Rigsby, Elmina E Akwo, Elmina E Mboh, Emily B Camire, Eric Zhu, Ernest Serna, III, Gabriel M Guevarra, Gail L Katz, Gene D Arcy, Gloria A Milster, Hoimay Chan, Iris C Macinnes, Janet B Abt, Janet Pulver, Jennifer A Baker, Jennifer L Custodio, Jerry E Lott, Jessie E Morris, Jocelyn E Massey, Juanelma H Palmer, Julian C Hanson, Ka L Wong, Karen J Bak, Kecia M Smith, Kenneth L Smalls, Kenneth S Boehnen, Kip J Hanks, Lakecha N Lewis, Laurissa S Flowers, Lee Terry Moore, Linda Thai, Lore Fields, Maira P Brading, Marion W Nadeau, Mark W Rivero, Mary Ewilkerson Brinsko, Mizanne E Lewis, Naveen B Walker, Nikisha M Bolden, Pauline N Logan, Peter Kessler, PhD, Randy D Baxter, Raymond W Brullo, Rebeca Ulloa, Richard J Bashay, Robert S Sweeton, Ronda Rloyd Jones, Roosevelt Turner, Sandra Jacquez, Sarah Forney, Shaquenta Y Perkins, Shelley H Beausoleil, Sidney M Smith, Sonya L Karsik, RAC, Stephen T Hansen, Steven E Porter, Jr, Tania Y Hall, Tawny L Colling, Teena H Aiken, Thao T Kwan, Tiana M Mckinley, Timothy P Lafave, Tracy J Washington, Trushani T Desai, Verdell Nelson, Vien Q Le, Vivian Garcia, Yaw O Osei, Young M Yoon, Yvette Mlacour Davis, Yvette S Montes, Yvonne C Wilkes, Yvonne T Lacour

Dylan R Jock's Documents

Publish Date	Document Type	Title
August, 2022	FDA 483	Cedars-Sinai Medical Center - Form 483, 2022-08-26
April, 2023	FDA 483	University Fertility Center - Form 483, 2023-04-03
February, 2024	FDA 483	Peyman Saadat MD, Inc. - Form 483, 2024-02-20
April, 2024	FDA 483	Utah Lions Eye Bank - Form 483, 2024-04-23
February, 2024	FDA 483	CSL Plasma Inc. - Form 483, 2024-02-01
May, 2023	FDA 483	Incinta Fertility Center, LLC - Form 483, 2023-05-02
July, 2024	FDA 483	California Center for Reproductive Health - Form 483, 2024-07-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more